CA
IONS icon

Cetera Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Cetera Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$709K Buy
+16,361
New +$780K 0.01% 1370

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cetera Advisors's IONS Position: Q1 2024 in Review

Cetera Advisors opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2024: 16,361 shares worth $709K. The stake represents 0.01% of the portfolio and ranks #1370 among its holdings.

361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Cetera Advisors held 16,361 shares of Ionis Pharmaceuticals worth $709K as of Q1 2024.
  • Ionis Pharmaceuticals was a new Cetera Advisors position in Q1 2024.
  • Ionis Pharmaceuticals made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #1370 holding.
  • 361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.